Clinical Trial Update: Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing bevacizumab to corticosteroids as first-line treatment for symptomatic cerebral radiation necrosis after radiotherapy for high-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• High-grade Glioma
• Radiation Necrosis

Drugs mentioned

• Bevacizumab (bevacizumab)
• Corticosteroids (corticosteroids)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Radiation Necrosis, High Grade Glioma (III or IV) | Phase 3 | Status: RECRUITING